169280-83-5

Basic information

• Product Name: TERT-BUTYL [5-(HYDROXYMETHYL)PYRIDIN-2-YL)CARBAMATE
• Synonyms: 2-(Boc-amino)-5-pyridinemethanol;2-(Boc-amino)-5-pyridinemethanol ,97%;tert-butyl 5-(hydroxyMeth...;2-(tert-Butoxycarbonylamino)-5-(hydroxymethyl)pyridine;6-(N-tert-Butoxycarbonylamino)-3-hydroxymethylpyridine;CarbaMic acid, N-[5-(hydroxyMethyl)-2-pyridinyl]-, 1,1-diMethylethyl ester;tert-butyl N-[5-(hydroxymethyl)pyridin-2-yl]carbamate;N-Boc-5-(hydroxymethyl)-2-pyridineamine
• CAS NO: 169280-83-5
• Molecular Formula: C₁₁H₁₆N₂O₃
• Molecular Weight: 224.26
• EINECS: -0
• Mol File: 169280-83-5.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 332.8 °C at 760 mmHg
• Flash Point: 155.1 °C
• Appearance: /
• Density: 1.209
• Vapor Pressure: 5.67E-05mmHg at 25°C
• Refractive Index: 1.567
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• PKA: 12.35±0.70(Predicted)
• CAS DataBase Reference: TERT-BUTYL [5-(HYDROXYMETHYL)PYRIDIN-2-YL)CARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL [5-(HYDROXYMETHYL)PYRIDIN-2-YL)CARBAMATE(169280-83-5)
• EPA Substance Registry System: TERT-BUTYL [5-(HYDROXYMETHYL)PYRIDIN-2-YL)CARBAMATE(169280-83-5)

Safety Data

• Statements: 36/37/38
• Safety Statements: 26-37
• Hazardous Substances Data: 169280-83-5(Hazardous Substances Data)

Usage

Chemical Properties

White solid

InChI:InChI=1/C11H16N2O3/c1-11(2,3)16-10(15)13-9-5-4-8(7-14)6-12-9/h4-6,14H,7H2,1-3H3,(H,12,13,15)

Upstream product

• 199296-40-7 2-(tert-butyloxycarbonyl)-aminopyridine-5-carboxaldehyde 
• 3167-49-5 6-aminonicotinic acid 
• 39658-41-8 ethyl-6-amino-nicotinate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1089330-72-2 ethyl 6-[bis(tert-butoxycarbonyl)amino]nicotinate 
• 169280-82-4 6-((tert-butoxycarbonyl)amino)nicotinic acid ethyl ester 
• 144186-11-8 methyl 6-<(tert-butyloxycarbonyl)amino>nicotinoate 
• 36052-24-1 methyl 6-aminonicotinoate 

Downstream Products

• 144186-12-9 carbonic acid 6-tert-butoxycarbonylamino-pyridin-3-ylmethyl ester 4-nitro-phenyl ester 
• 1585145-51-2 7-(2,6-dichloro-3,5-dimethoxyphenyl)-N-{5-[(4-methylpiperazin-1-yl)methyl]pyridin-2-yl}isoquinolin-3-amine 
• 1197333-44-0 5-(4-methyl-piperazin-1-ylmethyl)-pyridin-2-ylamine 
• 1585145-64-7 7-(2,6-difluoro-3,5-dimethoxyphenyl)-N-{5-[(4-methylpiperazin-1-yl)methyl]pyridin-2-yl}isoquinolin-3-amine 
• 1585145-71-6 7-(2-chloro-6-fluoro-3,5-dimethoxyphenyl)-N-[5-(4-methylpiperazin-1-ylmethyl)pyridin-2-yl]isoquinolin-3-amine 
• 1197331-07-9 8-(3,5-dimethoxy-phenyl)-quinoxaline-5-carboxylic acid [5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-amide 
• 1588422-80-3 3-(2,6-difluorophenyl)-1-ethyl-7-((5-((4-methylpiperazin-1-yl)methyl)pyridin-2-yl)amino)-1,6-naphthyridin-2(1H)-one 
• 199296-40-7 2-(tert-butyloxycarbonyl)-aminopyridine-5-carboxaldehyde 
• 1196073-33-2 TH-1254 
• 497159-99-6 dimethyl 2-({6-[(tert-butoxycarbonyl)amino]pyridin-3-yl}methyl)-2-{1-[(4-methylphenyl)sulfonyl]-1H-imidazol-4-yl}malonate 

Relevant articles and documents

SUBSTITUTED BICYCLIC AZA-HETEROCYCLES AND ANALOGUES AS SIRTUIN MODULATORS

Provided herein are novel substituted bicyclic aza-heterocycle sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

MULTIPLE KINASE PATHWAY INHIBITORS

Kinase with inhibitory activity against kinases disposed in multiple signaling pathways and their therapeutic uses.

BENZIMIDAZOLES AND RELATED ANALOGS AS SIRTUIN MODULATORS

Provided herein are sirtuin-modulating compounds of formula (II) The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.